[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600653":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":54,"collaborators":10,"id":58,"slug":10,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":69,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Complejo Hospitalario Universitario Insular Materno Infantil","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"ovarian cancer patients",null,[12],"Other: resection of infundibulopelvic ligament",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"resection of infundibulopelvic ligament","Therefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"beatriz NAVARRO SANTANA, pHD","CONTACT","+34620151146","bea_0904@hotmail.com",[25],{"facility":26,"status":27,"city":28,"state":10,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Complejo Universitario Insular Materno Infantil de Las Palmas","RECRUITING","Las Palmas de Gran Canaria","Spain","ES",{"type":32,"coordinates":33},"Point",[34,35],-15.41573,28.10178,{"lat":35,"lon":34},[38,42,43,46,48,50,52],{"name":39,"role":21,"phone":40,"phoneExt":10,"email":41},"Alicia Martin Martinez, phd","+34649088104","aliciammartinez@gmail.com",{"name":10,"role":21,"phone":10,"phoneExt":10,"email":23},{"name":44,"role":45,"phone":10,"phoneExt":10,"email":10},"Octavio Arencibia Sanchez, MD","SUB_INVESTIGATOR",{"name":47,"role":45,"phone":10,"phoneExt":10,"email":10},"DANIEL GONZALEZ, MD",{"name":49,"role":45,"phone":10,"phoneExt":10,"email":10},"Andres Rave, MD",{"name":51,"role":45,"phone":10,"phoneExt":10,"email":10},"Jesus Guijarro, MD",{"name":53,"role":45,"phone":10,"phoneExt":10,"email":10},"Alicia Martín Martínez, MD",{"type":55,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Beatriz Fatima Navarro Santana","GYNECOLOGIST ONCOLOGIST","100600653",false,"NCT07100288","Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer","INFPELV","Inclusion Criteria:\n\n* ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.\n\n  * FIGO 2014 stage IA-IVB.\n  * Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy\n  * Patients with no residual disease after surgery.\n  * Patients with ECOG performance status 0-1.\n\nExclusion Criteria:\n\n* ◦ Patients without epithelial ovarian cancer.\n\n  * Patients with ECOG 2-4.\n  * Patients who do not consent to participate in the study.\n  * Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.","FEMALE","18 Years",{"count":67,"type":68},200,"ESTIMATED","2 Years","OBSERVATIONAL","Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis",[73,74,75],"Ovarian Cancer","Ovarian Cancer (OvCa)","Ovarian Adenocarcinoma","2025-07-27",{"date":78,"type":79},"2025-08-03","ACTUAL",{"date":81,"type":79},"2025-07-20",{"date":83,"type":68},"2030-12-30",{"name":5,"class":6},1]